Trinity Biotech (TRIB) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Trinity Biotech plc has strategically bolstered its marketing leadership by appointing David Ouston as the new Biosensor Marketing Director, bringing his extensive experience in glucose monitoring and diabetes care to the company. Ouston’s expertise in global markets and digital solutions for diabetes management is expected to drive the growth and market penetration of Trinity’s innovative, needle-free, continuous glucose monitoring technology. His previous roles at Johnson & Johnson and LifeScan have equipped him with the skills to support Trinity Biotech’s mission to improve public health through wearable biosensor technology and wellness analytics.
For further insights into TRIB stock, check out TipRanks’ Stock Analysis page.